Uploaded June 2026 | Updated September 2026, 24 minutes ago
A reduction in obesity and metabolic health conditions would ease suffering for those living with the symptoms. It would also reduce NCDs and protect the global economy. What kind of evidence from practical interventions could prove this link and persuade governments to invest in obesity prevention? What is the potential for population-scale deals for GLP-1 drugs?
A reduction in obesity and metabolic health conditions would ease suffering for those living with the symptoms. It would also reduce NCDs and protect the global economy. What kind of evidence from practical interventions could prove this link and persuade governments to invest in obesity prevention? What is the potential for population-scale deals for GLP-1 drugs?










